SEC Filings TLDR

Amendment No. 25 to the Schedule 13D filed by Ludmila Smolyansky, Edward Smolyansky, and The Edward Smolyansky Trust 2/2/16 provides additional information regarding their holdings and intentions. Edward Smolyansky has notified Lifeway Foods, Inc. of his intent to nominate George Sent for election to the issuer's board...

This Amendment No. 3 to Schedule 13D, filed by Daniel R. Herndon and Lola W. Herndon, updates their ownership and intentions regarding the common stock of Home Federal Bancorp, Inc. of Louisiana. The filing reflects that the Reporting Persons have not engaged in any transactions involving the Issuer's common stock in t...

Liberty 77 Capital L.P. and related entities have filed an amendment to their Schedule 13D, disclosing an increased ownership of 24.9% in Flagstar Bank, N.A. The filing details the merger between Flagstar Bank, N.A. and its parent company, Flagstar Financial, Inc., which was completed on October 17, 2025. As a result o...

This Amendment No. 1 to Schedule 13D, filed by Capitol Acquisition Management IV LLC and related parties, updates the ownership details of Custom Truck One Source, Inc.'s common stock. The amendment reports a distribution in-kind of 3,670,279 shares of Common Stock to members of Management IV on October 17, 2025, with ...

This Amendment No. 4 to Schedule 13D, filed by Avraham Brenmiller, updates the ownership details of Brenmiller Energy Ltd.'s ordinary shares. The filing indicates that as of August 21, 2025, the Reporting Person has ceased to be the beneficial owner of more than five percent of the Issuer's outstanding ordinary shares....

GAMCO Investors, Inc. ET AL has filed an amendment to its Schedule 13D for Biglari Holdings Inc., reporting ownership of 13,435 shares of Class A Common Stock, representing 6.49% of the outstanding shares. The filing includes detailed information about the reporting persons, their business activities, and their transac...

Daniel S. Farb, a reporting person, has filed an amendment to Schedule 13D for Artelo Biosciences, Inc. The amendment updates the ownership details and transactions involving the company's common stock. As of October 20, 2025, Farb ceased to beneficially own more than 5% of the outstanding shares. The amendment include...

Michael Anthony Belfiore, a private investor from the United States, has filed a Schedule 13D/A amendment for AIRWA INC., disclosing his ownership of 3,213,095 shares of common stock, representing approximately 22.1% of the outstanding class. Belfiore acquired these shares through personal funds from IRA and brokerage ...

Impactive Capital LP has filed an amendment to its Schedule 13D for WEX Inc., disclosing changes in its ownership and intentions regarding the company. As of October 20, 2025, Impactive Capital beneficially owns approximately 6.4% of WEX Inc.'s common stock, totaling 2,195,253 shares. The filing also includes details a...

RA Capital Management, L.P., along with Peter Kolchinsky and Rajeev Shah, filed an amendment to their Schedule 13D, disclosing a reduction in their ownership of VOR Biopharma Inc. common stock. The filing indicates that RA Capital Management and its affiliates sold a significant number of shares, reducing their ownersh...

This Amendment No. 1 to Schedule 13D, filed by Atlas Venture Fund XI, L.P. and related entities, updates their ownership in Sionna Therapeutics, Inc. The reporting entities collectively own 7.0% of the company's outstanding common stock, with Atlas Venture Fund XI, L.P. holding 5.4% and Atlas Venture Opportunity Fund I...

This Amendment No. 5 to the Schedule 13D filed by the Reporting Persons (RSLGH, LLC, Wellness Mgmt, LLC, For Success Holding Company, VCP23, LLC, GTI23, Inc., and Green Thumb Industries Inc.) relates to the shares of common stock of RYTHM, Inc. The Reporting Persons collectively have voting and dispositive power over 1...

This Amendment No. 1 to Schedule 13D, filed by R01 Fund LP and related entities, updates the ownership details of NovaBay Pharmaceuticals, Inc. The amendment reports the convertibility of Series D Non-Voting Convertible Preferred Stock following stockholder approval and the issuance of Series E Preferred Stock, which i...

This Amendment No. 1 to Schedule 13D, filed by Framework Ventures IV L.P. and other reporting persons, updates the ownership details of NovaBay Pharmaceuticals, Inc. The amendment reports the convertibility of the Series D Non-Voting Convertible Preferred Stock following stockholder approval and the issuance of 134,375...

Blue Owl Capital Holdings LP has filed Amendment No. 2 to its Schedule 13D for Katapult Holdings, Inc. The amendment reflects changes in beneficial ownership due to an increase in the number of Conversion Shares acquirable pursuant to the Refinancing Agreement, driven by changes in the issuer's stock price. The Reporti...

Intercontinental Exchange, Inc. (ICE) and Intercontinental Exchange Holdings, Inc. (ICEH) filed Amendment No. 9 to their Schedule 13D regarding their holdings in Bakkt Holdings, Inc. The amendment reports the entry into a Tax Receivable Agreement (TRA) Amendment, a Contribution Agreement, and an Up-C Collapse Waiver. T...

This Amendment No. 2 to Schedule 13D, filed by Tong Tong Zhao, East Leader International Limited, and Perfect Will Holdings Limited, updates the ownership and control details of ordinary shares and American Depositary Shares (ADSs) of H World Group Limited. The amendment includes the revocation of a power of attorney p...

This Amendment No. 2 to Schedule 13D, filed by Qi Ji and Winner Crown Holdings Limited, updates the ownership and transaction details of ordinary shares and American Depositary Shares (ADSs) of H World Group Limited. The amendment includes information on the revocation of a power of attorney previously granted to Qi Ji...

This filing is an amendment to the Schedule 13D for Gyrodyne, LLC, filed by Star Equity Fund, LP and related entities. The amendment includes a settlement agreement between Star Equity and Gyrodyne, LLC, dated October 16, 2025. The agreement outlines the withdrawal of Star Equity's nomination of two candidates for the ...

The Schedule 13D amendment filed by The Waterproof Partnership, Ltd., The Loewenbaum 1992 Trust, The Loewenbaum Residence Trust FBO Anna Loewenbaum, and The Elizabeth Scott Loewenbaum 1992 Trust, collectively referred to as the Reporting Entities, along with individual filers George Walter Loewenbaum, Elizabeth S. Loew...

Intercontinental Exchange, Inc. (ICE) and Intercontinental Exchange Holdings, Inc. (ICEH) filed Amendment No. 9 to their Schedule 13D regarding their holdings in Bakkt Holdings, Inc. The amendment reports the entry into a Tax Receivable Agreement (TRA) Amendment, a Contribution Agreement, and an Up-C Collapse Waiver. T...

This Amendment No. 7 to Schedule 13D is filed by Heritage Assets SCSp, M Management S.A., and Manfredi Lefebvre d'Ovidio (collectively, the 'Reporting Persons') with respect to the Ordinary Shares of Arqit Quantum Inc. The amendment updates the aggregate number of Ordinary Shares and percentage of Ordinary Shares benef...

This Amendment No. 3 to Schedule 13D, filed on October 20, 2025, provides updated information regarding the beneficial ownership of Ordinary Shares of ATAI Life Sciences N.V. by Apeiron Investment Group Ltd., Apeiron Presight Capital Fund II, L.P., Presight Capital Management I, L.L.C., Fabian Hansen, and Christian Ang...

Reprogrammed Interchange LLC, along with Reid Hoffman, filed Amendment No. 8 to Schedule 13D, reporting a reduction in their stake in Vor Biopharma Inc. The amendment details multiple open market transactions from October 15, 2025, through October 16, 2025, where Reprogrammed Interchange LLC sold shares of Vor Biopharm...

Pictet Asset Management SA, a Swiss investment adviser, filed an amendment to its Schedule 13D for Tetra Tech Inc., disclosing ownership of 13,006,243 shares, representing 4.9% of the company's common stock. The shares are held on behalf of institutional clients managed on a discretionary basis. Pictet Asset Management...